journal article·2018-08-08

Keratin-Templated Synthesis of Metallic Oxide Nanoparticles as MRI Contrast Agents and Drug Carriers

Yan Li, Kai Song, Yu Cao, Chen Peng, Guang Yang

ACS Applied Materials & Interfaces· Volume 10· Issue 31
Publisher page

Abstract

Keratin is a family of cysteine-rich structural fibrous proteins abundantly present in skin and skin appendages. Inspired by the template synthesis strategy, in this work, keratin was utilized for the first time as a platform template to synthesize metallic oxide nanoparticles, such as MnO2 (MnNPs@Keratin) and Gd2O3 (GdNPs@Keratin), in a simple and environment-benign fashion. These nanoparticles possess good colloid stability and biocompatibility, high T1 relaxivity (r1 value = 6.8 mM−1s−1 for MnNPs@Keratin and 7.8 mM−1s−1 for GdNPs@Keratin), and superior in vivo magnetic resonance imaging performance of tumor. Moreover, these keratin-templated nanoparticles have great potential as drug carriers with the capacity of redox-responsive drug release due to the existence of disulfide cross-linking in keratin coating. These results suggest that keratin can be a promising platform template for the development of metal-based nanoparticles for cancer diagnosis and therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Gold and Silver Nanoparticles Synthesis and Applications · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China

Department of Radiology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai 200072, China

Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, and North Carolina State University, Raleigh, North Carolina 27695, United States

Funding

Natural Science Foundation of Shanghai · Ministry of Education of the People's Republic of China

References (31)

Show source-provided references
1. Pierre V. C. · 2014
2. 10.1039/c4cs00336e10.1039/c4cs00336e ↗
3. 10.1021/nn900761s10.1021/nn900761s ↗
4. 10.1002/ange.20060477510.1002/ange.200604775 ↗
5. 10.1002/adma.20150022910.1002/adma.201500229 ↗
6. 10.1021/ja806804u10.1021/ja806804u ↗
7. 10.1021/bm500438x10.1021/bm500438x ↗
8. 10.1039/C4NR02623C10.1039/C4NR02623C ↗
9. 10.1016/j.progpolymsci.2014.08.00210.1016/j.progpolymsci.2014.08.002 ↗
10. 10.1002/adhm.20160086510.1002/adhm.201600865 ↗
11. 10.1039/C8CS00011E10.1039/C8CS00011E ↗
12. 10.1002/adma.20160190210.1002/adma.201601902 ↗
13. 10.1002/adfm.20160344010.1002/adfm.201603440 ↗
14. 10.1039/C6TB02308H10.1039/C6TB02308H ↗
15. 10.1021/ar200177710.1021/ar2001777 ↗
16. 10.1038/aps.2017.4210.1038/aps.2017.42 ↗
17. 10.1002/adma.20150570010.1002/adma.201505700 ↗
18. 10.1021/bm300690310.1021/bm3006903 ↗
19. 10.1038/natrevmats.2016.7510.1038/natrevmats.2016.75 ↗
20. 10.1039/C5CS00798D10.1039/C5CS00798D ↗
21. 10.1038/nrd433310.1038/nrd4333 ↗
22. 10.1016/j.ijpharm.2016.12.01710.1016/j.ijpharm.2016.12.017 ↗
23. 10.1007/s11837-012-0302-810.1007/s11837-012-0302-8 ↗
24. 10.1016/j.biomaterials.2009.09.07610.1016/j.biomaterials.2009.09.076 ↗
25. 10.1039/C4PY01750A10.1039/C4PY01750A ↗
26. 10.1039/c2jm34136k10.1039/c2jm34136k ↗
27. 10.1021/acs.bioconjchem.5b0028910.1021/acs.bioconjchem.5b00289 ↗
28. 10.1016/j.msec.2016.12.06710.1016/j.msec.2016.12.067 ↗
29. 10.1021/acsami.6b1524710.1021/acsami.6b15247 ↗
30. 10.1002/adfm.20160592610.1002/adfm.201605926 ↗
31. 10.1002/ange.20171202710.1002/ange.201712027 ↗